Intraoperative tumor detection using a ratiometric activatable fluorescent peptide: a first-in-human phase 1 study
JT Unkart, SL Chen, IL Wapnir, JE González… - Annals of surgical …, 2017 - Springer
Background Positive surgical margins remain a significant challenge in breast cancer
surgery. This report describes the use of a novel, first-in-human ratiometric activatable cell-
penetrating peptide in breast cancer surgery. Methods A two-part, multi-institutional phase 1
surgery. This report describes the use of a novel, first-in-human ratiometric activatable cell-
penetrating peptide in breast cancer surgery. Methods A two-part, multi-institutional phase 1
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论